Azfar-E-Alam Siddiqi1, H Irene Hall, Xiaohong Hu, Ruiguang Song. 1. *HIV Incidence and Case Surveillance Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA; and †Quantitative Sciences and Data Management Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
INTRODUCTION: Using National HIV surveillance system data, we estimated life expectancy and average years of life lost (AYLL) among persons diagnosed with HIV infection during 2008-2011. METHODS: Population-based surveillance data, restricted to persons with diagnosed HIV infection aged 13 years or older, from all 50 states and Washington, D.C. were used to estimate life expectancy after HIV diagnosis using the life table method. Generated estimates were compared with life expectancy in the general population in the same calendar year to calculate AYLL. Life expectancy and AYLL were also estimated for subgroups by age, sex, and race/ethnicity. RESULTS: The overall life expectancy after HIV diagnosis in the United States increased by 3.43 years from 25.43 (95% CI: 25.37 to 25.49) in 2008 to 28.86 (95% CI: 28.80 to 28.92) in 2011. Improvements were observed irrespective of sex, race/ethnicity, transmission category, and stage of disease at diagnosis, though the extent of improvement varied by different characteristics. Based on the life expectancy in the general population, in 2010, the AYLL were 12.8 years for males and 16.5 years for females. By race/ethnicity, on average, blacks (13.3 years) and whites (13.4 years) had fewer AYLL than Hispanics/Latinos (14.7). CONCLUSIONS: Despite improvements in life expectancy among people diagnosed with an HIV infection during 2008-2011, disparities by sex and by race/ethnicity persist. Targeted efforts should continue to further reduce disparities and improve life expectancy after HIV diagnosis.
INTRODUCTION: Using National HIV surveillance system data, we estimated life expectancy and average years of life lost (AYLL) among persons diagnosed with HIV infection during 2008-2011. METHODS: Population-based surveillance data, restricted to persons with diagnosed HIV infection aged 13 years or older, from all 50 states and Washington, D.C. were used to estimate life expectancy after HIV diagnosis using the life table method. Generated estimates were compared with life expectancy in the general population in the same calendar year to calculate AYLL. Life expectancy and AYLL were also estimated for subgroups by age, sex, and race/ethnicity. RESULTS: The overall life expectancy after HIV diagnosis in the United States increased by 3.43 years from 25.43 (95% CI: 25.37 to 25.49) in 2008 to 28.86 (95% CI: 28.80 to 28.92) in 2011. Improvements were observed irrespective of sex, race/ethnicity, transmission category, and stage of disease at diagnosis, though the extent of improvement varied by different characteristics. Based on the life expectancy in the general population, in 2010, the AYLL were 12.8 years for males and 16.5 years for females. By race/ethnicity, on average, blacks (13.3 years) and whites (13.4 years) had fewer AYLL than Hispanics/Latinos (14.7). CONCLUSIONS: Despite improvements in life expectancy among people diagnosed with an HIV infection during 2008-2011, disparities by sex and by race/ethnicity persist. Targeted efforts should continue to further reduce disparities and improve life expectancy after HIV diagnosis.
Authors: Janni J Kinsler; Mitchell D Wong; Jennifer N Sayles; Cynthia Davis; William E Cunningham Journal: AIDS Patient Care STDS Date: 2007-08 Impact factor: 5.078
Authors: Leigh F Johnson; Joel Mossong; Rob E Dorrington; Michael Schomaker; Christopher J Hoffmann; Olivia Keiser; Matthew P Fox; Robin Wood; Hans Prozesky; Janet Giddy; Daniela Belen Garone; Morna Cornell; Matthias Egger; Andrew Boulle Journal: PLoS Med Date: 2013-04-09 Impact factor: 11.069
Authors: C Prussing; C Chan; J Pinchoff; L Kersanske; K Bornschlegel; S Balter; A Drobnik; J Fuld Journal: Epidemiol Infect Date: 2014-08-29 Impact factor: 4.434
Authors: Michael S Leapman; Kimberly Stone; Roxanne Wadia; Lesley S Park; Cynthia L Gibert; Matthew B Goetz; Roger Bedimo; Maria Rodriguez-Barradas; Fatma Shebl; Amy C Justice; Sheldon T Brown; Kristina Crothers; Keith M Sigel Journal: J Urol Date: 2021-09-24 Impact factor: 7.600
Authors: Kathleen V Fitch; Christopher DeFilippi; Robert Christenson; Suman Srinivasa; Hang Lee; Janet Lo; Michael T Lu; Kimberly Wong; Eva Petrow; Laura Sanchez; Sara E Looby; Udo Hoffmann; Markella Zanni; Steven K Grinspoon Journal: AIDS Date: 2016-09-10 Impact factor: 4.177
Authors: Caitlin A Moran; Geoffrey Southmayd; Chandan M Devireddy; Arshed A Quyyumi; Ighovwerha Ofotokun; Henry A Liberman; Wissam Jaber; Anandi N Sheth Journal: AIDS Date: 2020-01-01 Impact factor: 4.632
Authors: Márton Kolossváry; Elliot K Fishman; Gary Gerstenblith; David A Bluemke; Raul N Mandler; David Celentano; Thomas S Kickler; Sarah Bazr; Shaoguang Chen; Shenghan Lai; Hong Lai Journal: Eur Radiol Date: 2021-03-03 Impact factor: 7.034
Authors: Sarah Nietz; Daniel S O'Neil; Oluwatosin Ayeni; Wenlong Carl Chen; Maureen Joffe; Judith S Jacobson; Alfred I Neugut; Paul Ruff; Witness Mapanga; Ines Buccimazza; Urishka Singh; Sharon Čačala; Laura Stopforth; Boitumelo Phakathi; Tobias Chirwa; Herbert Cubasch Journal: Breast Cancer Res Treat Date: 2020-09-01 Impact factor: 4.872